Berlin, December 7, 2022-Current recommendations on the supply bottleneck of nanoparticle albumin-bound paclitaxel (nab-paclitaxel)

被引：0
|
作者：
不详
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 02期
关键词：
PANCREATIC-CANCER; CHEMOTHERAPY; GEMCITABINE; FOLFIRINOX; SURVIVAL;
D O I：
10.1055/a-1998-7964
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [41] Binding affinities of paclitaxel and docetaxel for generic and nanoparticle albumin-bound paclitaxel-derived albumin from human serum
    Sato, Takamichi
    Okazaki, Manami
    Sano, Junko
    Kato, Chihiro
    Shimizu, Kazuhisa
    Kitagawa, Masayuki
    BIOMEDICAL REPORTS, 2021, 14 (04)
  • [42] Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma
    Huang, Yan
    Liang, Wenhua
    Yang, Yunpeng
    Zhao, Liping
    Zhao, Hongyun
    Wu, Xuan
    Zhao, Yuanyuan
    Zhang, Yang
    Zhang, Li
    BMC CANCER, 2016, 16
  • [43] Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma
    Yan Huang
    Wenhua Liang
    Yunpeng Yang
    Liping Zhao
    Hongyun Zhao
    Xuan Wu
    Yuanyuan Zhao
    Yang Zhang
    Li Zhang
    BMC Cancer, 16
  • [44] Superior therapeutic efficacy of nanoparticle albumin-bound paclitaxel over cremophor-bound paclitaxel in experimental esophageal adenocarcinoma
    Hassan, Md Sazzad
    Awasthi, Niranjan
    Schwarz, Roderich E.
    Schwarz, Margaret A.
    von Holzen, Urs
    CANCER RESEARCH, 2017, 77
  • [45] Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.
    Khasraw, Mustafa
    Mukaro, Violet Rudo
    West, Linda
    White, Karen
    Rippy, Elisabeth
    Brandt, Conrad
    Tobler, Robert
    Murphy, Caitlin Clare
    Collins, Ian M.
    Baron-Hay, Sally E.
    Ashley, David M.
    Patil, Sujata
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study
    Goyal, Sagun
    Oak, Eunhye
    Luo, Jingqin
    Cashen, Amanda F.
    Carson, Kenneth
    Fehniger, Todd
    DiPersio, John
    Bartlett, Nancy L.
    Wagner-Johnston, Nina D.
    LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 357 - 362
  • [47] Outcomes and Costs of Nanoparticle Albumin-Bound(nab-) Paclitaxel Compared to Docetaxel in Women with Pretreated Metastatic Breast Cancer
    Donatti, Christina M.
    McLeod, Euan
    Lloyd, Adam
    Prunieras, Francois J.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 113 - 113
  • [48] Combined modality treatment with ABI-007, nanoparticle albumin-bound (nab) paclitaxel:: modification of radiation response in vivo
    Wiedenmann, N.
    Valdecanas, D.
    Hunter, N.
    Farrar, D.
    Milas, L.
    Mason, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 97 - 97
  • [49] Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer
    Zhang, Dong-sheng
    Wang, De-shen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Luo, Hui-yan
    Qiu, Miao-zhen
    Wang, Feng
    Li, Yu-hong
    Xu, Rui-hua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 1065 - 1072
  • [50] An NMR Protocol for In Vitro Paclitaxel Release from an Albumin-Bound Nanoparticle Formulation
    Min Sung Suh
    Sharadrao M. Patil
    Darby Kozak
    Eric Pang
    Stephanie Choi
    Xiaohui Jiang
    Jason D. Rodriguez
    David A. Keire
    Kang Chen
    AAPS PharmSciTech, 21
12345